Common Stock, Shares, Issued of Propanc Biopharma, Inc. from 30 Jun 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Propanc Biopharma, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 30 Jun 2011 to 31 Dec 2025.
  • Propanc Biopharma, Inc. Common Stock, Shares, Issued for the quarter ending 31 Dec 2025 was 13,449,688.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 13,449,688 +13,435,180 31 Dec 2025 10-Q 17 Feb 2026 2026 Q2
Q3 2025 12,806,748 -675,215,269 -98% 30 Sep 2025 10-Q 14 Nov 2025 2026 Q1
Q2 2025 11,611,782 +11,603,802 30 Jun 2025 10-Q 17 Feb 2026 2026 Q2
Q1 2025 11,611,782 -98,094,629 -89% 31 Mar 2025 10-Q 15 May 2025 2025 Q3
Q4 2024 14,508* -36,154,515 31 Dec 2024 10-Q 14 Feb 2025 2025 Q2
Q3 2024 688,022,017 +673,188,807 +4538% 30 Sep 2024 10-Q 14 Nov 2024 2025 Q1
Q2 2024 7,980* -6,023,270 30 Jun 2024 10-K 29 Sep 2025 2025 FY
Q1 2024 109,706,411 -2,511,591,375 -96% 31 Mar 2024 10-Q 15 May 2024 2024 Q3
Q4 2023 36,169,023 -1,209,530,478 -97% 31 Dec 2023 10-Q 20 Feb 2024 2024 Q2
Q3 2023 14,833,210 -662,344,507 -98% 30 Sep 2023 10-Q 14 Nov 2023 2024 Q1
Q2 2023 6,031,250 +5,810,899 +2637% 30 Jun 2023 10-K 30 Sep 2024 2024 FY
Q1 2023 2,621,297,786 +2,536,267,760 +2983% 31 Mar 2023 10-Q 15 May 2023 2023 Q3
Q4 2022 1,245,699,501 +1,192,637,292 +2248% 31 Dec 2022 10-Q 10 Feb 2023 2023 Q2
Q3 2022 677,177,717 +633,336,073 +1445% 30 Sep 2022 10-Q 14 Nov 2022 2023 Q1
Q2 2022 220,351 -13,835,042 -98% 30 Jun 2022 10-K 28 Sep 2023 2023 FY
Q1 2022 85,030,026 +80,061,202 +1611% 31 Mar 2022 10-Q 16 May 2022 2022 Q3
Q4 2021 53,062,209 +51,615,375 +3567% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q2
Q3 2021 43,841,644 -671,755,571 -94% 30 Sep 2021 10-Q 12 Nov 2021 2022 Q1
Q2 2021 14,055,393 +13,797,273 +5345% 30 Jun 2021 10-K 28 Sep 2022 2022 FY
Q1 2021 4,968,824 -13,512,635 -73% 31 Mar 2021 10-Q 14 May 2021 2021 Q3
Q4 2020 1,446,834 -788,067 -35% 31 Dec 2020 10-Q 12 Feb 2021 2021 Q2
Q3 2020 715,597,215 +714,427,234 +61063% 30 Sep 2020 10-Q 16 Nov 2020 2021 Q1
Q2 2020 258,120 -709,922 -73% 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q1 2020 18,481,459 -366,732,010 -95% 31 Mar 2020 10-Q 15 May 2020 2020 Q3
Q4 2019 2,234,901 -271,041,883 -99% 31 Dec 2019 10-Q 14 Feb 2020 2020 Q2
Q3 2019 1,169,981 -174,413,990 -99% 30 Sep 2019 10-Q 14 Nov 2019 2020 Q1
Q2 2019 968,042 +875,183 30 Jun 2019 10-K 01 Oct 2020 2020 FY
Q1 2019 385,213,469 +354,128,859 +1139% 31 Mar 2019 10-Q 15 May 2019 2019 Q3
Q4 2018 273,276,784 +255,583,500 +1445% 31 Dec 2018 10-Q 14 Feb 2019 2019 Q2
Q3 2018 175,583,971 +168,909,225 +2531% 30 Sep 2018 10-Q 13 Nov 2018 2019 Q1
Q2 2018 92,859* -4,485,425 30 Jun 2018 10-K 15 Oct 2019 2019 FY
Q1 2018 31,084,610 +27,340,515 +730% 31 Mar 2018 10-Q 10 May 2018 2018 Q3
Q4 2017 17,693,284 -849,588,450 -98% 31 Dec 2017 10-Q 09 Feb 2018 2018 Q2
Q3 2017 6,674,746 -787,249,998 -99% 30 Sep 2017 10-Q 09 Nov 2017 2018 Q1
Q2 2017 4,578,284 +1,663,819 +57% 30 Jun 2017 10-K 17 Sep 2018 2018 FY
Q1 2017 3,744,095 -598,709,959 -99% 31 Mar 2017 10-Q 08 May 2017 2017 Q3
Q4 2016 867,281,734 +434,561,848 +100% 31 Dec 2016 10-Q 14 Feb 2017 2017 Q2
Q3 2016 793,924,744 +437,300,147 +123% 30 Sep 2016 10-Q 10 Nov 2016 2017 Q1
Q2 2016 2,914,465 -344,527,548 -99% 30 Jun 2016 10-K 28 Sep 2017 2017 FY
Q1 2016 602,454,054 +269,673,710 +81% 31 Mar 2016 10-Q 16 May 2016 2016 Q3
Q4 2015 432,719,886 +301,945,301 +231% 31 Dec 2015 10-Q 16 Feb 2016 2016 Q2
Q3 2015 356,624,597 +273,830,497 +331% 30 Sep 2015 10-Q 16 Nov 2015 2016 Q1
Q2 2015 347,442,013 +274,757,246 +378% 30 Jun 2015 10-K 28 Sep 2016 2016 FY
Q1 2015 332,780,344 +260,095,576 +358% 31 Mar 2015 10-Q 15 May 2015 2015 Q3
Q4 2014 130,774,585 +58,089,817 +80% 31 Dec 2014 10-Q 17 Feb 2015 2015 Q2
Q3 2014 82,794,100 +10,964,332 +15% 30 Sep 2014 10-Q 19 Nov 2014 2015 Q1
Q2 2014 72,684,767 +2,052,500 +2.9% 30 Jun 2014 10-K 30 Sep 2015 2015 FY
Q1 2014 72,684,768 +2,052,500 +2.9% 31 Mar 2014 10-Q 20 May 2014 2014 Q3
Q4 2013 72,684,768 -135,571 -0.19% 31 Dec 2013 10-Q 14 Feb 2014 2014 Q2
Q3 2013 71,829,768 -875,801 -1.2% 30 Sep 2013 10-Q 14 Nov 2013 2014 Q1
Q2 2013 70,632,267 -2,073,302 -2.9% 30 Jun 2013 10-K 14 Oct 2014 2014 FY
Q1 2013 70,632,268 -1,521,008 -2.1% 31 Mar 2013 10-Q 20 May 2013 2013 Q3
Q4 2012 72,820,339 +817,063 +1.1% 31 Dec 2012 10-Q 20 Feb 2013 2013 Q2
Q3 2012 72,705,569 30 Sep 2012 10-Q 19 Nov 2012 2013 Q1
Q2 2012 72,705,569 +789,679 +1.1% 30 Jun 2012 10-K 15 Oct 2013 2013 FY
Q1 2012 72,153,276 31 Mar 2012 10-Q 21 May 2012 2012 Q3
Q4 2011 72,003,276 31 Dec 2011 10-Q/A 07 Mar 2012 2012 Q2
Q2 2011 71,915,890 30 Jun 2011 10-K 15 Oct 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.